Johnson & Johnson JNJ
NYSE JNJ
$276.17 +3.84 (+1.41%)
At close: Nov 6, 2026 · 4:00 PM EST

Johnson & Johnson (JNJ) Purchase of Investments (2009 - 2026)

Updated

Johnson & Johnson's Purchase of Investments - Total came in at $919 million for Q3 2026, up 273.6% from $246 million a year earlier and up 492.9% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Purchase of Investments (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 27, 2026, Johnson & Johnson reported Purchase of Investments - Total of $1.46 billion, up 55.6% year-over-year; for FY2025, it came in at $920 million, down 46.7% from FY2024.

  • Purchase of Investments - Total has declined in each of the last three years, with a four-year compound annual growth rate of -54.3% (FY2021 to FY2025).
  • Going back by year, Purchase of Investments - Total was $1.73 billion in FY2024 (-84.2%), $10.91 billion in FY2023 (-66.3%), $32.38 billion in FY2022 and $21.09 billion in FY2021.
  • The Q3 2026 figure represents the highest quarterly Purchase of Investments - Total since Q4 2023.
  • Year-over-year, Purchase of Investments - Total increased in 1 of the last eight quarters, with an average decline of 0.2%.
  • The fastest year-over-year change in Purchase of Investments - Total over five years came in Q3 2026 (growth of 273.6%), and the weakest in Q4 2023 (a decline of 93.2%).
  • Business Quant data shows JNJ's Purchase of Investments - Total at $155 million (Q2 2026), $144 million (Q1 2026) and $243 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 258.00 Mn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 919.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 300.00 Mn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 1.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 4.40 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2026 919.00 Mn
Jun 28, 2026 155.00 Mn
Mar 29, 2026 144.00 Mn
Dec 28, 2025 243.00 Mn
Sep 28, 2025 246.00 Mn
Jun 29, 2025 180.00 Mn
Mar 30, 2025 251.00 Mn
Dec 29, 2024 262.00 Mn
Sep 29, 2024 280.00 Mn
Jun 30, 2024 554.00 Mn
Mar 31, 2024 630.00 Mn
Dec 31, 2023 925.00 Mn
Oct 1, 2023 293.00 Mn
Jul 2, 2023 5.91 Bn
Apr 2, 2023 3.77 Bn
Jan 1, 2023 13.54 Bn
Apr 3, 2022 9.02 Bn
Oct 3, 2021 6.58 Bn
Jul 4, 2021 6.27 Bn
Apr 4, 2021 5.99 Bn
API Access

Johnson & Johnson Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=JNJ&period=max&api_key=YOUR_API_KEY